The genetic defect-Adenosine Deaminase deficiency may be cured permanently by
(a) periodic infusion of genetically engineered lymphocytes having functional ADA C-DNA
(b) administering adenosine deaminase activators
(c) introducing bone marrow cells producing ADA into cells at early embrayonic stages
(d) enzyme replacement therapy